Vetnostrum Animal Health Co., Ltd. (TPE:6936)
Taiwan · Delayed Price · Currency is TWD 33.70
0.00 (0.00%)
At close: Jun 4, 2026
Vetnostrum Animal Health Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 137.43 | 128.85 | 136.62 | 91.6 | 106.52 |
Depreciation & Amortization | 72.35 | 73.49 | 75.94 | 76.74 | 78.22 |
Other Amortization | 0.2 | 0.2 | 0.21 | - | - |
Loss (Gain) From Sale of Assets | 0.15 | 0.15 | 1.89 | -0.04 | 0.05 |
Loss (Gain) From Sale of Investments | 9.17 | 3.66 | - | - | - |
Stock-Based Compensation | 8.3 | 8.3 | - | - | 5.3 |
Provision & Write-off of Bad Debts | - | - | - | -0.1 | 0.01 |
Other Operating Activities | -7.26 | -8.42 | 12.78 | -4.18 | -1.12 |
Change in Accounts Receivable | -19.27 | -1.75 | -28.05 | 10.74 | 10.41 |
Change in Inventory | 88.72 | 72.83 | -56.19 | 13.72 | -34.12 |
Change in Accounts Payable | 21.88 | 10.98 | 12.6 | 24.44 | -26.28 |
Change in Unearned Revenue | - | - | - | - | -4.36 |
Change in Other Net Operating Assets | -5.52 | 0.65 | 24.59 | 22.57 | -7.06 |
Operating Cash Flow | 306.15 | 288.93 | 180.39 | 235.49 | 127.56 |
Operating Cash Flow Growth | 49.24% | 60.17% | -23.40% | 84.61% | - |
Capital Expenditures | -32.29 | -25.65 | -30.2 | -15.49 | -22.05 |
Sale of Property, Plant & Equipment | - | - | - | 0.04 | 0.36 |
Investment in Securities | -346.98 | -311.86 | -10 | - | - |
Other Investing Activities | 1.39 | 0.74 | -0.44 | -0.33 | 3.87 |
Investing Cash Flow | -377.87 | -336.77 | -40.64 | -15.78 | -17.83 |
Short-Term Debt Issued | - | 60 | 350 | 580 | 970 |
Total Debt Issued | - | 60 | 350 | 580 | 970 |
Short-Term Debt Repaid | - | -60 | -420 | -700 | -890 |
Long-Term Debt Repaid | - | -11.43 | -9.09 | -8.56 | -148.42 |
Total Debt Repaid | -31.41 | -71.43 | -429.09 | -708.56 | -1,038 |
Net Debt Issued (Repaid) | -31.41 | -11.43 | -79.09 | -128.56 | -68.42 |
Issuance of Common Stock | 207.46 | 207.46 | 0.83 | 1.27 | 53 |
Common Dividends Paid | -122.73 | -122.73 | -68.94 | -80.12 | -82.5 |
Financing Cash Flow | 53.33 | 73.31 | -147.2 | -207.4 | -97.92 |
Net Cash Flow | -18.4 | 25.47 | -7.46 | 12.31 | 11.81 |
Free Cash Flow | 273.86 | 263.28 | 150.19 | 220 | 105.51 |
Free Cash Flow Growth | 54.99% | 75.30% | -31.74% | 108.51% | - |
Free Cash Flow Margin | 18.97% | 18.59% | 11.61% | 18.22% | 8.90% |
Free Cash Flow Per Share | 3.76 | 3.71 | 2.26 | 3.31 | 1.66 |
Cash Interest Paid | 0.44 | 0.56 | 1.15 | 2.17 | 2.94 |
Cash Income Tax Paid | 37.92 | 38.66 | 18.96 | 25.15 | 26.43 |
Levered Free Cash Flow | 231.88 | 231.7 | 118.21 | 204.08 | - |
Unlevered Free Cash Flow | 232.15 | 232.05 | 118.9 | 205.32 | - |
Change in Working Capital | 85.81 | 82.71 | -47.05 | 71.47 | -61.4 |